Drug Product & Formulation Analysis
Formulation quality is the cornerstone of consistent drug performance, reliable bioavailability, and seamless global regulatory approval. PharmaAnalytica delivers GMP-compliant, pharmacopoeia-aligned Drug Product & Formulation Analysis tailored for oral solids, semisolids, and transdermal dosage forms. Our centralized, audit-ready analytical laboratory covers the full development lifecycle, from early-formulation feasibility screening and pilot-scale batch characterization to routine commercial release and long-term stability monitoring. All raw data, electronic records, and final test reports are fully traceable and compliant with USP, EP, and FDA expectations, streamlining your regulatory submission timeline and reducing internal QC laboratory burdens.
Specialized Drug Product & Formulation Analysis Services
Dissolution & Release Test
Our compendial-compliant dissolution and in vitro drug release testing adheres strictly to USP <711> and EP monographs, precisely mimicking dynamic gastrointestinal pH and temperature physiological conditions for IR, MR, ER, and DR oral solid dosage forms. Equipped with fully calibrated, multi-channel dissolution stations with complete electronic audit trails, we offer dedicated method development, full analytical validation, routine batch release testing, and real-time stability dissolution profiling. High-fidelity in vitro release data directly supports IVIVC modelling, bioequivalence study justification, critical formulation iteration, and cross-region regulatory dossier compilation, eliminating non-compliant data risks for clinical and commercial registration batches.
Hardness, Friability, Disintegration Test
We perform full-spectrum physical characterization testing for solid oral dosage forms, including quantitative tablet hardness compression testing, standardized friability abrasion evaluation, and compendia-compliant disintegration endpoint verification under controlled physiological temperature conditions. These critical physical CQA indicators directly govern manufacturing batch uniformity, logistics and distribution mechanical tolerance, and predictable in vivo gastrointestinal disintegration behaviour. We deliver timestamped raw datasets, traceable calibration certificates, and fully compliant audit-ready documentation, fully supporting routine GMP factory batch release, internal quality deviation investigation, and global authority on-site GMP inspections without supplementary rectification.
Semisolid Rheology / Viscosity Analysis
We deliver tailored professional rheological profiling and precision viscosity measurement for all semisolid drug formulations, including pharmaceutical creams, therapeutic ointments, topical gels, and medicinal pastes. Our testing focuses on key functional rheological attributes: shear-thinning flow behaviour, critical yield stress values, structural thixotropic recovery, and real-time temperature-dependent viscosity drift. Well-controlled rheological signatures ensure uniform topical spreading, accurate reproducible dosing, long-term shelf-life physical stability, and seamless high-speed industrial filling compatibility. Our high-resolution rotational rheometer testing effectively guides excipient thickener ratio optimization, minimizes inter-batch physical variability, and locks in consistent commercial-grade formulation texture performance.
Transdermal Permeation (Franz Diffusion Cell) Test
We utilize validated vertical Franz diffusion cell systems to conduct standardized in vitro transdermal permeation performance assessment for transdermal patches, topical liniments, and dermatological therapeutic gels. Using industry-qualified synthetic barrier membranes and biological skin equivalents, we closely simulate clinical human percutaneous absorption microenvironments to quantify key permeation kinetics: active drug flux rate, cumulative percutaneous penetration dose, and steady-state transdermal delivery efficiency. Generated high-quality data accelerates penetration enhancer screening, backing layer and adhesive compatibility optimization, and robust IVIVC correlation studies. All testing workflows fully comply with global dermatological and transdermal product registration technical review standards.
Content Uniformity Analysis with HPLC
We provide fully validated HPLC-based content uniformity testing programmes, specifically optimized for low-potency single-unit oral solids, high-sensitivity active pharmaceutical ingredients, and complex fixed-dose combination drug products. Following strict pharmacopoeial statistical uniformity criteria, we accurately identify unit-to-unit API content divergence, root-cause powder blending inhomogeneity, particle segregation risks, and tableting process irregularities. Our standardized workflow features low-loss sample preparation, robust chromatographic system suitability control, full data integrity compliance, and complete traceability chains, guaranteeing that final finished dosage units meet stringent international batch uniformity regulatory specifications.
Why Choose PharmaAnalytica?
Formulation-Specific Customized Testing Strategy
We tailor every testing scheme to match your unique dosage form properties, development stage, and global filing targets. Flexible method adaptation and targeted CQA-focused testing avoid redundant routine experiments, precisely matching pilot optimization, formal batch production and cross-region registration full-cycle application scenarios.
Full Regulatory & Data Integrity Compliance
All operations follow GMP, USP, EP and FDA ALCOA+ data integrity rules with complete audit trails and calibrated equipment records. Every raw dataset and final report is fully defensible and directly ready for global regulatory inspections and official registration dossiers.
Expert CMC Team & Fast Project Delivery
Our senior pharma analytical specialists deliver efficient method deployment, real-time transparent progress updates and concise technical interpretation. We shorten testing turnaround cycles without compromising data quality, supporting fast batch release and urgent formulation troubleshooting.
Cost-Efficient Outsourcing Solution
Outsource your full formulation testing portfolio to lower in-house instrument investment, QC manpower costs and internal facility maintenance burdens. You gain scalable, high-quality analytical capacity while stabilizing long-term drug development and commercial operation budgets.
Ready to streamline your drug product lifecycle with reliable, regulatory-ready formulation analysis? Connect with the PharmaAnalytica CMC technical team today to discuss your project requirements, secure a customized testing roadmap, and accelerate your dosage form development and global regulatory submission progress with proven analytical expertise.
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Need More Information or Request A Quotation?
Related Links
